Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype

Extracellular matrix (ECsM) bioscaffolds have been successfully used to treat five esophageal adenocarcinoma (EAC) patients following resection of neoplastic mucosal tissue. The present study evaluated the in vitro effect of ECM harvested from nonmalignant, decellularized tissue on EAC cell phenotyp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Tissue Eng Part A
Autores principales: Saldin, Lindsey T., Patel, Shil, Zhang, Li, Huleihel, Luai, Hussey, George S., Nascari, David G., Quijano, Lina M., Li, Xue, Raghu, Divya, Bajwa, Anant K., Smith, Nicholas G., Chung, Christopher C., Omstead, Ashten N., Kosovec, Juliann E., Jobe, Blair A., Turner, Neill J., Zaidi, Ali H., Badylak, Stephen F.
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6450457/
https://ncbi.nlm.nih.gov/pubmed/30259795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ten.tea.2018.0105
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares